Drug and biotech companies are coming to the defense of the FDA and assailing a Texas court's ruling on abortion pills. They say it sets a dangerous precedent for undermining federal drug approvals.
Drug and biotech companies are coming to the defense of the Food and Drug Administration and assailing a Texas court's ruling on abortion pills, saying it sets a dangerous precedent for undermining federalIf the ruling is upheld, FDA decisions could be stayed by individual judges, injecting chaos into the regulatory process and creating new potential liabilities for manufacturers.
"For a court to invalidate the approval of a drug that was reviewed and approved more than two decades ago is without precedent," BIO interim president and CEO, Rachel King, said in a statement. "As legal scholars have noted, the courts do not have the medical expertise to make these types of scientific determinations."
"You're talking about every kind of drug. You're talking about our vaccines. You're talking about insulin. You're talking about the new Alzheimer's drugs that may come on,"
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Drug companies blast Texas judge for abortion drug decision, call for reversalHundreds of pharmaceutical firms including Pfizer wrote an open letter condemning a federal judge in Texas who halted the approval of abortion drug mifepristone.
Read more »
Hundreds of pharma execs call for reversal of Texas abortion pill rulingOne of the pharmaceutical industry’s central concerns is that if a judge can overturn FDA approval of Mifepristone, all drugs are vulnerable to similar rulings.
Read more »
DOJ asks appeals court to stay Texas ruling against FDA abortion drug approvalThe Justice Department asked the U.S. Court of Appeals for the 5th Circuit to stay a Texas judge's order to suspend the Food and Drug Administration's approval of a common abortion drug, asking for intervention no later than Thursday at noon.
Read more »
Analysis: Texas abortion pill ruling could undermine US drug regulatorA federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said.
Read more »
Texas Abortion Pill Ruling Could Undermine US Drug RegulatorA federal judge's decision last week to suspend the FDA approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said.
Read more »
US appeals Texas abortion pill ruling as states stockpile the drugThe U.S. government on Monday appealed a Texas judge's decision to suspend the Food and Drug Administration's 23-year-old approval of a key abortion drug, saying the ruling endangered women's health by blocking access to a pill long deemed safe.
Read more »